Open AccessBloodless Operations in the Surgical Treatment of Mitral-Aortic Heart Disease in Conditions of Artificial Circulation
Author(s) -
B. M. Gumeniuk,
В. В. Попов
Publication year - 2020
Publication title -
ukraïnsʹkij žurnal sercevo-sudinnoï hìrurgìï
Language(s) - English
Resource type - Journals
eISSN - 2664-5971
pISSN - 2664-5963
DOI - 10.30702/ujcvs/20.3803/006032-036
Subject(s) - medicine , perioperative , aortic valve replacement , surgery , perfusion , mitral valve , mitral valve replacement , cardiology , blood transfusion , blood volume , anesthesia , stenosis
Traditional mitral and aortic valve replacement in conditions of artificial blood circulation (ABC) involves the use of blood products. Given various complications arising in perioperative period, the authors propose a technique for “bloodless operations” without the use of donor blood, without the use of columns, and the “sell-saver” method. From January 1, 2011 to December 31, 2018, mitral-aortic valve replacement was performed in 79 patients; in 42 of them blood products were used during surgery, and in 37 patients donor blood components were not used. The method of anaesthetic and infusion-perfusion measures for mitral-aortic valve replacement in conditions of ABC is given. The use of the blood-saving method has allowed to obtain good clinical effect without transfusion complications in perioperative period, which facilitated the use of bloodless methods for mitral-aortic valve replacement in the main group in conditions of ABC and reduce blood transfusions in perioperative period from 27.4 % to 10.3 % of the circulating blood volume (CBV), compared to the control group. In the variant of reservation of autoblood “A+B+C” and exfusion of 27.2% of the CBV, the most effective variants of the blood-saving) technology were observed during mitral-aortic valve repair in conditions of ABC.